ACMAT Corporation
ACMTA
$29.05
-$4.45-13.28%
| Weiss Ratings | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.03 | |||
| Price History | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -13.28% | |||
| 90-Day Total Return | -13.28% | |||
| Year to Date Total Return | -13.28% | |||
| 1-Year Total Return | -13.28% | |||
| 2-Year Total Return | -17.00% | |||
| 3-Year Total Return | -11.97% | |||
| 5-Year Total Return | -17.00% | |||
| 52-Week High % Change | -3.17% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $30.00 | |||
| 52-Week Low Price | $29.05 | |||
| 52-Week Low Price (Date) | Jul 02, 2024 | |||
| 52-Week High Price (Date) | Jul 02, 2024 | |||
| Valuation | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 29.10M | |||
| Enterprise Value | 27.29M | |||
| Price/Earnings (TTM) | 17.36 | |||
| Earnings Per Share (TTM) | 1.67 | |||
| Earnings Per Share Growth | -219.39% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 7.34 | |||
| Price/Book (Q) | 0.78 | |||
| Enterprise Value/Revenue (TTM) | 7.27 | |||
| Price | $29.05 | |||
| Enterprise Value/EBITDA (TTM) | 15.65 | |||
| Enterprise Value/EBIT | 17.97 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 771.10K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 860-415-8400 | |||
| Address | 30 South Road Farmington, CT 06032-2418 | |||
| Website | www.acmatcorp.com | |||
| Country | United States | |||
| Year Founded | 1950 | |||
| Profitability | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 40.48% | |||
| Profit Margin | 42.29% | |||
| Management Effectiveness | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.52% | |||
| Return on Equity | 4.64% | |||
| Income Statement | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.00M | |||
| Total Revenue (TTM) | 3.05M | |||
| Revenue Per Share | $3.96 | |||
| Gross Profit (TTM) | 4.00M | |||
| EBITDA (TTM) | 1.42M | |||
| EBIT (TTM) | 1.24M | |||
| Net Income (TTM) | 1.29M | |||
| Net Income Avl. to Common (TTM) | 1.29M | |||
| Total Revenue Growth (Q YOY) | 72.76% | |||
| Earnings Growth (Q YOY) | 63.29% | |||
| EPS Diluted (TTM) | 1.67 | |||
| EPS Diluted Growth (Q YOY) | 63.27% | |||
| Balance Sheet | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.14M | |||
| Cash Per Share (Q) | $5.37 | |||
| Total Current Assets (Q) | 5.73M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 28.65M | |||
| Current Ratio (Q) | 3.036 | |||
| Book Value Per Share (Q) | $37.13 | |||
| Total Assets (Q) | 52.60M | |||
| Total Current Liabilities (Q) | 1.89M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 23.95M | |||
| Total Common Equity (Q) | 28.65M | |||
| Cash Flow | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.05M | |||
| Cash from Financing (TTM) | -13.50K | |||
| Net Change in Cash (TTM) | 939.00K | |||
| Levered Free Cash Flow (TTM) | 1.72M | |||
| Cash from Operations (TTM) | 3.00M | |||
